Table 3. Results of the selected metabolites in breast cancer patients post-radiotherapy (RT), and segregated with respect to whether or not they received adjuvant hormone therapy.
Results are shown as means and SD (in parenthesis).
| Variable | Metabolite concentrations post-RT | |
|---|---|---|
| Hormone therapy NO | Hormone therapy YES | |
| Pyruvate (μM) | 84.26 (32.25) | 72.42 (27.48) |
| Lactate (μM) | 578.60 (111.08) | 541.46 (112.91) |
| Alanine (μM) | 231.06 (92.05) | 206.97 (80.33) |
| Hydroxybutyrate (μM) | 20.11 (15.72) | 25.91 (23.10) |
| Valine (μM) | 141.59 (75.31) | 121.49 (72.50) |
| Leucine (μM) | 68.97 (41.21) | 58.07 (37.34) |
| Isoleucine (μM) | 29.93 (21.50) | 24.08 (18.33) |
| Proline (μM) | 90.23 (59.08) | 76.01 (51.43) |
| Malonyl Coenzyme A (μM) | 1.50 (0.39) | 1.36 (0.43) |
| Glycine (μM) | 122.82 (38.32) | 103.04 (40.01) * |
| Succinate (μM) | 11.62 (3.01) | 11.04 (2.79) |
| Fumarate (μM) | 0.62 (0.33) | 0.48 (0.24) |
| Serine (μM) | 39.31 (31.19) | 35.03 (30.44) |
| Oxaloacetate (μM) | 36.41 (14.08) | 35.70 (11.20) |
| Malate (μM) | 2.59 (1.46) | 2.02 (0.97) |
| Aspartate (μM) | 16.10 (7.14) | 15.98 (6.30) |
| Ketoglutarate (μM) | 4.78 (2.72) | 4.17 (1.84) |
| Glutamate (μM) | 44.84 (24.13) | 52.98 (22.38) |
| Aconitate (μM) | 0.50 (0.34) | 0.56 (0.31) |
| Citrate (μM) | 57.44 (14.41) | 53.38 (12.90) |
| Glutamine (μM) | 75.01 (23.31) | 66.83 (22.30) |
* P < 0.05